Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

1933 Industries Inc C.TGIF

Alternate Symbol(s):  TGIFF

1933 Industries Inc. is a Canada-based cannabis cultivator and producer. The Company is focused on the cultivation and manufacturing of a portfolio of cannabis consumer-packaged goods in a variety of formats for both the wholesale and retail markets. Its product offerings through its in-house brands, including wholesale flower, pre-rolls, and extracted products under the AMA and Level X brands for the Nevada market; and Canna Hemp, a national cannabidiol (CBD) brand of wellness products, which include tinctures, gummies, topicals and sports recovery products. The Company owns 91% of Alternative Medicine Association, LC (AMA) and 100% of Infused MFG LLC (Infused). AMA is a licensed medical and adult-use cannabis cultivation and extraction company, which produced its own AMA branded line of cannabis-based products and manufactures third-party brands. Infused produces the Canna Hemp line of hemp-based, CBD products. Infused’s product line includes topicals, creams, vapes and others.


CSE:TGIF - Post by User

Post by jfogarty12on Jun 11, 2022 1:22pm
351 Views
Post# 34749366

from BNN - another eye opener

from BNN - another eye opener
Analyst Call of the Week - BMO Capital Markets downgrades Canopy Growth   

BMO Capital Markets Analyst Tamy Chen published an update on the firm’s two-year outlook on the cannabis industry with a tough message for some investors to swallow: most of the challenges currently seen in the industry are set to continue unabated for the foreseeable future. That includes how consumer demand is still driven by THC and price, rather than any focus on terpenes or other marketable points, as well as how dried flower will remain a dominant category amid a lack of significant interest in edibles. Perhaps more importantly, Chen believes there won’t be any “meaningful rationalization” of Canadian cannabis producers and the country’s “punitive” excise tax regime and distribution system that places the lion’s share of control on provinces will continue to exist. “We believe the incremental opportunity from further illicit market displacement is much less than most LPs’ expectations,” Chen said. As a result of those various challenges on the industry’s supply chain, Chen thinks the industry is projected to grow in the single-digits in 2024 and onward.   She noted that Village Farms International, which owns the Pure Sunfarms cannabis producer, is BMO’s top pick in their coverage universe with a US$6-per-share price target and the only firm in the 10 cannabis companies she tracks to be awarded an outperform rating (the equivalent of a buy). Chen is also cautiously optimistic on Cronos Group’s long-term prospects while maintaining reservations on Organigram and Tilray’s business models. Chen also downgraded Canopy Growth to underperform (the equivalent of a sell) and a $2.50-per-share target price following the company’s latest quarterly results that show ongoing challenges in selling competitive products and how some of its cost savings are unlikely to impact its bottom line. “Every LP likely struggles from time to time with suboptimal crops, yet we have not seen another company report a [gross margin] as low as Canopy’s,” she said.


<< Previous
Bullboard Posts
Next >>